Cytosorbents Corporation Financial Ratios — CTSO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-155.7	-246.41	-145.87	-126.56	-189.32	-18.97	-34.64	-67	-99.38	-119.8	-96.39
Return on Assets (%)	-278.65	-134.15	-126.68	-148.98	-96.1	-112.31	-50.07	-59.04	-62.57	-13.36	-27.37	-42.96	-50.34	-41.3	-17.91
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	67.4	-110.65	-132.61	32.14	45.45	51.82	58.76	63.02	67.65	71.99	72.46	52.47	70.62	69.92	71.48
EBITDA Margin (%)	-12,189.19	-2,267.03	-565.7	-217.11	-226.61	-138.08	-71.92	-75.03	-80.79	-24.61	-53.89	-103.51	-96.27	-41.32	-34.02
Operating Margin (%)	-12,297.71	-2,303.06	-573.53	-219.2	-229.39	-140.04	-73.55	-76.95	-83.34	-26.29	-56.71	-107.36	-102.78	-46.22	-38.42
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-15,193.88	-2,675.43	-624.99	-308.7	-241.67	-147.23	-68.28	-88.04	-89.42	-22.72	-63.07	-115.48	-96.7	-62.96	-23.2
Profit Margin (%)	-15,193.88	-2,416.98	-569.22	-296.44	-233.67	-143.35	-63.23	-84.98	-84.63	-19.86	-61.23	-111.76	-94.09	-58.21	-22.12
Net Income to Common Margin (%)	-23,750.46	-4,073.86	-860.72	-591.13	-233.67	-143.35	-63.23	-84.98	-84.63	-19.86	-61.23	-111.76	-94.09	-58.21	-22.12
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	36.03	40.67	33.87	49.85	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-155.7	-246.41	-145.87	-126.56	-189.32	-18.97	-34.64	-67	-99.38	-119.8	-96.39

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1	1	2	- -	- -	5	10	11	16	1	14	18	18	27	29
ST Debt	- -	1	2	- -	- -	1	4	1	2	- -	1	- -	3	- -	1
LT Debt	- -	- -	- -	- -	- -	4	6	10	14	1	13	18	15	26	29
Total Debt/EBITDA	-0.13	-0.27	-0.35	- -	- -	-0.43	-1.04	-0.75	-0.88	-0.11	-0.64	-0.6	-0.61	-1.83	-2.31
Net Debt/EBITDA	0.14	0.23	0.12	0.53	0.58	0.03	0.76	0.82	-0.15	7.36	2.41	0.56	0.3	-0.73	-0.83
Total Debt/EBIT	-0.13	-0.27	-0.35	- -	- -	-0.43	-1.02	-0.73	-0.85	-0.1	-0.61	-0.58	-0.57	-1.63	-2.04
Net Debt/EBIT	0.14	0.23	0.11	0.52	0.57	0.03	0.74	0.8	-0.15	6.89	2.29	0.54	0.28	-0.65	-0.73
EBITDA to Interest Expense	-4.21	-6.09	-10.99	-22.02	-988.14	-48.88	-12.85	-10.4	-17.79	-8.08	- -	- -	-189.53	-10.51	-4.83
EBITDA-CapEx/Interest Expense	-4.26	-6.16	-11.51	-23.21	-1,057.32	-51.45	-15.09	-11.44	-19.26	-9.48	- -	- -	-195.46	-10.99	-5.01
EBIT to Interest Expense	-4.25	-6.18	-11.15	-22.23	-1,000.29	-49.58	-13.14	-10.67	-18.36	-8.63	- -	- -	-202.35	-11.76	-5.45
Interest Expense	1	1	- -	- -	- -	- -	1	1	1	1	- -	- -	- -	1	3
Common Equity/Total Assets	-475.44	-348.17	-352.65	46.8	72.95	13.8	42.58	49.52	12.48	88.07	69.9	55.95	44.34	23.45	13.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	304.93	58.39	61.09	410.42	0.73	21.18	51.28	65.75	238.05	483.99
Long-Term Debt/Capital (%)	-2.9	- -	- -	- -	- -	65.26	29.58	36.52	71.79	0.72	17.34	33.83	36.94	69.58	81.6
Long-Term Debt/Total Assets (%)	13.02	- -	- -	- -	- -	42.07	24.86	30.25	51.23	0.65	14.8	28.69	29.16	55.81	64.66
Total Debt/Equity (%)	-5.65	-7.97	-11.53	- -	- -	367.24	97.36	67.26	471.7	1.3	22.09	51.59	77.99	242.13	493.16
Total Debt/Capital (%)	-5.99	-8.66	-13.03	- -	- -	78.6	49.33	40.21	82.51	1.28	18.09	34.03	43.82	70.77	83.14
Total Debt/Total Assets (%)	26.88	27.74	40.64	- -	- -	50.67	41.46	33.31	58.88	1.14	15.44	28.86	34.58	56.77	65.89
Net Debt to Equity	6.11	6.91	3.78	-90.97	-64.76	-24.94	-71.42	-73.39	82.5	-90.16	-83.32	-48.47	-38.7	96.48	176.49
Net Debt/Capital (%)	5.75	6.46	3.64	-1,007.33	-183.74	-33.22	-249.9	-208.64	38.58	-809.48	-214.89	-54.46	-32.85	30.86	36.22
EBITDA	-4	-3	-5	-7	-9	-11	-10	-15	-18	-10	-22	-30	-30	-15	-13
EBITDA-CapEx	-4	-3	-5	-7	-10	-12	-11	-17	-20	-11	-26	-37	-31	-15	-13
Operating Income (Loss)	-4	-3	-5	-7	-9	-11	-10	-16	-19	-10	-23	-32	-32	-16	-14

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.78	0.83	0.71	1.23	2.47	1.23	2.21	3.23	1.23	7.03	3.81	2.28	1.01	0.33	0.64
Current Ratio	1.11	1.42	1.14	1.69	3.24	1.83	2.64	4.09	2.1	8.12	4.7	3.48	1.81	2.2	2.13
Quick Ratio	0.8	0.86	0.86	1.41	2.68	1.56	2.49	3.8	1.68	7.54	4.14	2.86	1.44	1.08	1.42
CFO/Avg Current Liab	-2.79	-2.01	-1.36	-1.66	-2.4	-1.84	-1.07	-1.47	-1.99	-0.56	-1.17	-2.41	-1.82	-1.21	-1.27
Common Equity/Total Assets	-475.44	-348.17	-352.65	46.8	72.95	13.8	42.58	49.52	12.48	88.07	69.9	55.95	44.34	23.45	13.36
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	304.93	58.39	61.09	410.42	0.73	21.18	51.28	65.75	238.05	483.99
Long-Term Debt/Capital (%)	-2.9	- -	- -	- -	- -	65.26	29.58	36.52	71.79	0.72	17.34	33.83	36.94	69.58	81.6
Long-Term Debt/Total Assets (%)	13.02	- -	- -	- -	- -	42.07	24.86	30.25	51.23	0.65	14.8	28.69	29.16	55.81	64.66
Total Debt/Equity (%)	-5.65	-7.97	-11.53	- -	- -	367.24	97.36	67.26	471.7	1.3	22.09	51.59	77.99	242.13	493.16
Total Debt/Capital (%)	-5.99	-8.66	-13.03	- -	- -	78.6	49.33	40.21	82.51	1.28	18.09	34.03	43.82	70.77	83.14
Total Debt/Total Assets (%)	26.88	27.74	40.64	- -	- -	50.67	41.46	33.31	58.88	1.14	15.44	28.86	34.58	56.77	65.89
CFO/Total Liabilities	-31.35	-24.17	-19.06	-139.41	-297.25	-80.55	-46.68	-62.79	-69.93	-52.29	-51.99	-101.36	-73.47	-39.78	-32.33
CFO/CapEx	-72.94	-93.19	-16.13	-17.1	-14.06	-11.3	-3.85	-7.13	-11.02	-3.35	-3.27	-4.37	-23.13	-21.57	-25.21
Altman's Z-Score	-74.02	-46.3	-43.02	7.01	8.56	-16.6	-1.54	1.27	-8.95	17.21	0.73	-5.36	-8.09	-9.03	-9.97

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	2	3.45	3.26	4.94	5.53	7.88	7.35	6.59	5.41	8.2	8.28	5.76	5.3	5.32	4.98
Days Sales Outstanding	182.5	105.78	112.1	73.83	66.06	46.31	49.63	55.41	67.42	44.53	44.06	63.33	68.82	68.59	73.22
Inventory Turnover	0.05	0.57	4.12	5.45	2.56	3.91	6.77	9.2	5	4.62	2.97	3.39	2.67	3.51	2.64
Days Inventory Outstanding	6,688.9	636.38	88.6	66.98	142.55	93.46	53.89	39.69	73.04	79.06	122.91	107.59	136.65	104.11	138.34
Accounts Payable Turnover	0.59	0.77	1.86	3.27	4.14	3.49	3.74	4.28	3.73	4.52	4.16	3.98	2.87	2.82	4.23
Accounts Payable Turnover Days	615.31	471.99	196.41	111.71	88.07	104.5	97.56	85.35	97.83	80.7	87.73	91.68	127.26	129.5	86.37
Cash Conversion Cycle	6,256.1	270.17	4.29	29.11	120.54	35.27	5.96	9.75	42.63	42.88	79.24	79.25	78.21	43.2	125.2
Inventory to Cash Days	-6,506.4	-530.6	23.51	6.85	-76.5	-47.15	-4.26	15.72	-5.62	-34.53	-78.85	-44.26	-67.83	-35.53	-65.12
Inventories	- -	1	- -	1	1	1	1	1	2	3	5	3	3	3	5
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1
Work In Process	- -	- -	- -	- -	1	- -	1	- -	- -	- -	- -	1	1	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	2	4
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	2	3	5	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	29	28	32	233	142	140	189	258	126	346	183	68	61	50	40
- Cash & Cash Equivalents	1	2	2	4	5	5	17	22	12	71	52	22	14	3	6
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	1	1	2	- -	- -	5	10	11	16	1	14	18	18	27	29
Enterprise Value	28	27	31	227	135	139	182	247	130	276	145	64	65	74	63
Total Capital	-10	-11	-13	4	8	6	20	28	20	80	76	54	42	38	35
Total Debt/Capital (%)	-5.99	-8.66	-13.03	- -	- -	78.6	49.33	40.21	82.51	1.28	18.09	34.03	43.82	70.77	83.14
Total Debt / EV	0.02	0.03	0.05	- -	- -	0.04	0.05	0.05	0.12	- -	0.1	0.28	0.28	0.36	0.46
EV/Sales	774.63	180	37.76	72.34	33.2	16.97	13.6	12.2	5.71	6.99	3.61	2.18	2.08	2.07	1.7
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	26	26	30	144	139	139	180	249	125	311	183	68	50	50	40
Diluted Enterprise Value	25	25	29	140	134	139	173	238	129	241	144	64	54	73	63
EV per Share	3.91	3.16	3.07	9.71	5.28	5.44	6.25	7.74	3.97	6.35	3.31	1.46	1.19	1.34	1
TTM Sales	- -	- -	1	3	4	8	13	20	23	39	40	29	31	36	37
TTM EBITDA	-4	-3	-5	-7	-9	-11	-10	-15	-18	-10	-22	-30	-30	-15	-13
TTM Operating Income	-4	-3	-5	-7	-9	-11	-10	-16	-19	-10	-23	-32	-32	-16	-14
TTM Cash Flow to Firm	-3	-3	-3	-6	-9	-7	-6	-9	-16	-5	-14	-28	-22	-13	-10
TTM Free Cash Flow to Firm	-3	-3	-3	-6	-8	-6	-4	-8	-14	-3	-10	-22	-21	-12	-9

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-6.82	-7.24	-9.06	-24.32	-16.58	-22.7	-37.72	-26.77	-8.19	-78.97	-18.78	-3.12	-2.39	-3.6	-3.35
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	28	27	31	227	135	139	182	247	130	276	145	64	65	74	63
Low Price	2.75	1.62	2	3	5.17	3.11	3.3	6.45	3.49	3.6	3.88	1.03	0.91	0.7	0.6
EV/Sales	774.63	180	37.76	72.34	33.2	16.97	13.6	12.2	5.71	6.99	3.61	2.18	2.08	2.07	1.7
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.36	-4.38	-3.81	-4.62	-20.09	-10.53	-17.57	-17.74	-10.41	-39.44	-14.02	-3.1	-4.01	-2.58	-7.22
Price/Earnings High	-9.02	-6.1	-5.03	-10.01	-40.22	-14.99	-23.12	-26.82	-14.84	-58.44	-20.73	-5.78	-7.01	-4.18	-12.22
Price/Earnings Low	-2.07	-2.1	-2.68	-2.33	-13.64	-6.76	-10.82	-11.57	-5.87	-17.92	-6.88	-1.37	-1.39	-1.84	-4.55
Price/Book Value	-2.83	-2.42	-2.21	58.8	17.31	104.36	18.44	15.24	36.92	4.37	2.93	1.92	2.58	4.51	6.8
Price/Book Value Average	-3.16	-2.52	-2.01	35.11	23.67	92.75	15.2	18.65	59.34	4.34	5.52	2.88	6.1	4.86	10.12
Price/Book Value High	-8.49	-3.51	-2.66	76.04	47.38	132.13	20	28.19	84.58	6.44	8.16	5.37	10.66	7.89	17.13
Price/Book Value Low	-1.95	-1.21	-1.42	17.73	16.07	59.55	9.36	12.16	33.47	1.97	2.71	1.28	2.11	3.47	6.38
Price/Tangible Book Value	-2.77	-2.37	-2.16	68.43	19.11	953.68	22.47	18.03	2,228.44	4.62	3.16	2.19	3.09	6.79	15
Price/Tangible Book Value Average	-3.1	-2.48	-1.96	40.86	26.13	847.62	18.51	22.07	3,581.45	4.59	5.97	3.29	7.31	7.31	22.31
Price/Tangible Book Value High	-8.31	-3.45	-2.59	88.48	52.29	1,207.41	24.37	33.36	5,105.16	6.8	8.82	6.13	12.78	11.86	37.77
Price/Tangible Book Value Low	-1.91	-1.19	-1.38	20.63	17.74	544.21	11.41	14.39	2,020.07	2.09	2.93	1.46	2.54	5.22	14.08
Price/Sales	714.15	170.86	36.08	45.74	34.35	16.98	13.48	12.32	5.48	7.88	4.55	2.31	1.59	1.39	1.07
Price/Sales Average	797.74	178.34	32.81	27.31	46.95	15.09	11.11	15.08	8.81	7.83	8.58	3.46	3.77	1.5	1.6
Price/Sales High	2,142.46	248.4	43.29	59.14	93.98	21.49	14.62	22.79	12.56	11.61	12.69	6.46	6.59	2.43	2.7
Price/Sales Low	490.98	85.43	23.09	13.79	31.88	9.69	6.84	9.83	4.97	3.56	4.22	1.54	1.31	1.07	1.01
Price/Cash Flow	-6.73	-7.16	-8.5	-22.9	-15.4	-20.7	-27.92	-23.01	-7.45	-55.39	-13.04	-2.4	-2.29	-3.43	-3.21
Price/Cash Flow Average	-7.52	-7.47	-7.73	-13.67	-21.05	-18.39	-23.01	-28.17	-11.97	-55.06	-24.58	-3.6	-5.41	-3.7	-4.78
Price/Cash Flow High	-20.19	-10.41	-10.2	-29.61	-42.13	-26.2	-30.28	-42.58	-17.06	-81.59	-36.35	-6.72	-9.47	-6	-8.1
Price/Cash Flow Low	-4.63	-3.58	-5.44	-6.9	-14.29	-11.81	-14.17	-18.37	-6.75	-25.02	-12.07	-1.6	-1.88	-2.64	-3.02
Price/Free Cash Flow Average	-7.62	-7.56	-8.24	-14.52	-22.66	-20.18	-31.08	-32.76	-13.16	-78.51	-35.41	-4.67	-5.66	-3.88	-4.98
Price/Free Cash Flow High	-20.47	-10.52	-10.87	-31.45	-45.35	-28.75	-40.91	-49.52	-18.76	-116.33	-52.36	-8.71	-9.89	-6.29	-8.43
Price/Free Cash Flow Low	-4.69	-3.62	-5.8	-7.33	-15.38	-12.96	-19.15	-21.37	-7.42	-35.67	-17.39	-2.07	-1.96	-2.77	-3.14
EV/Sales Average	867.28	188.11	34.28	43.11	46.61	15.08	11.11	15.05	9.08	6.94	7.65	3.34	4.74	2.18	2.23
EV/Sales High	2,357.95	264.09	45.45	94.68	94.6	21.49	14.79	23.03	12.87	11.14	11.77	6.33	8.18	3.12	3.35
EV/Sales Low	527.23	87.36	23.93	21.2	31.22	9.67	6.63	9.63	5.2	2.18	3.27	1.41	1.73	1.75	1.63
EV/EBITDA Average	-7.12	-8.3	-6.06	-19.85	-20.57	-10.92	-15.44	-20.06	-11.24	-28.19	-14.2	-3.22	-4.92	-5.28	-6.55
EV/EBITDA High	-19.34	-11.65	-8.03	-43.61	-41.74	-15.57	-20.57	-30.7	-15.93	-45.27	-21.85	-6.12	-8.5	-7.56	-9.83
EV/EBITDA Low	-4.33	-3.85	-4.23	-9.76	-13.78	-7	-9.22	-12.83	-6.43	-8.86	-6.07	-1.36	-1.8	-4.23	-4.8
EV/EBIT Average	-7.05	-8.17	-5.98	-19.67	-20.32	-10.77	-15.1	-19.56	-10.89	-26.4	-13.5	-3.11	-4.61	-4.72	-5.8
EV/EBIT High	-19.17	-11.47	-7.92	-43.19	-41.24	-15.35	-20.11	-29.93	-15.44	-42.39	-20.76	-5.9	-7.96	-6.76	-8.71
EV/EBIT Low	-4.29	-3.79	-4.17	-9.67	-13.61	-6.9	-9.02	-12.51	-6.23	-8.29	-5.77	-1.31	-1.69	-3.78	-4.25
Last Price	4	3.25	3.12	9.95	5.57	5.45	6.5	8.08	3.85	7.97	4.19	1.55	1.11	0.91	0.64
High Price	12	4.72	3.75	12.87	15.24	6.9	7.05	14.95	8.82	11.74	11.68	4.33	4.59	1.59	1.61
Enterprise Value Average	31	29	28	136	189	124	149	305	207	274	307	98	147	78	83
Enterprise Value High	85	40	37	298	384	176	198	466	293	440	472	186	254	111	124
Enterprise Value Low	19	13	20	67	127	79	89	195	118	86	131	41	54	62	61

Shares Outstanding	7	9	10	23	26	26	29	32	33	43	44	44	55	55	63
Diluted Weighted Avg Shares	6	8	9	14	25	26	28	31	32	39	44	44	45	54	62
Basic Weighted Avg Shares	6	8	9	14	25	26	28	31	32	39	44	44	45	54	62
Revenue per Share	0.01	0.02	0.09	0.22	0.16	0.32	0.48	0.66	0.7	1.01	0.92	0.67	0.7	0.65	0.6
EBITDA per Share	-0.68	-0.43	-0.49	-0.47	-0.37	-0.44	-0.35	-0.49	-0.57	-0.25	-0.5	-0.69	-0.67	-0.27	-0.2
Operating Income per Share	-0.69	-0.44	-0.5	-0.48	-0.37	-0.45	-0.35	-0.5	-0.59	-0.27	-0.52	-0.72	-0.72	-0.3	-0.23
Basic EPS, GAAP	-1.33	-0.77	-0.75	-1.29	-0.38	-0.46	-0.3	-0.56	-0.59	-0.2	-0.56	-0.75	-0.65	-0.38	-0.13
Basic EPS from Cont Ops	-0.85	-0.46	-0.49	-0.64	-0.38	-0.46	-0.3	-0.56	-0.59	-0.2	-0.56	-0.75	-0.65	-0.38	-0.13
Diluted EPS, GAAP	-1.33	-0.77	-0.75	-1.29	-0.38	-0.46	-0.3	-0.56	-0.59	-0.2	-0.56	-0.75	-0.65	-0.38	-0.13
Diluted EPS from Cont Ops	-0.85	-0.46	-0.49	-0.64	-0.38	-0.46	-0.3	-0.56	-0.59	-0.2	-0.56	-0.75	-0.65	-0.38	-0.13
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.59	-0.45	-0.37	-0.43	-0.36	-0.26	-0.23	-0.35	-0.52	-0.14	-0.32	-0.64	-0.48	-0.27	-0.2
Free Cash Flow per Basic Share	-0.6	-0.46	-0.39	-0.46	-0.39	-0.29	-0.29	-0.4	-0.56	-0.19	-0.42	-0.79	-0.51	-0.28	-0.21
Cash & Equivalents per Share	0.17	0.2	0.22	0.24	0.29	0.2	0.59	0.7	0.37	1.64	1.19	0.5	0.26	0.06	0.1
Book Value per Share	-1.41	-1.35	-1.41	0.17	0.32	0.05	0.35	0.53	0.1	1.82	1.43	0.81	0.43	0.2	0.09
Tangible Book Value per Share	-1.44	-1.37	-1.45	0.15	0.29	0.01	0.29	0.45	- -	1.73	1.32	0.71	0.36	0.13	0.04

Cytosorbents Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)